Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Trends in industrialization of biotherapeutics: a survey of product characteristics of 89 antibody-based biotherapeutics
Kyle P. Martin, Christine Grimaldi, Rolf Grempler, et al.
mAbs (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Effect of Ozoralizumab Administration with or without Methotrexate in Patients with Rheumatoid Arthritis: A Post-Hoc Analysis
Yoshiya Tanaka, Nobuko Horiuchi, Cosmo Sasajima, et al.
Rheumatology and Therapy (2025)
Open Access | Times Cited: 1
Next-Generation Anti-TNFα Agents: The Example of Ozoralizumab
Kouhei Tsumoto, Tsutomu Takeuchi
BioDrugs (2024) Vol. 38, Iss. 3, pp. 341-351
Open Access | Times Cited: 6
How can we discover developable antibody-based biotherapeutics?
Joschka Bauer, Nandhini Rajagopal, Priyanka Gupta, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 16
Automated Online-Sampling Multidimensional Liquid Chromatography with Feedback-Control Capability as a Framework for Real-Time Monitoring of mAb Critical Quality Attributes in Multiple Bioreactors
Zachary D. Dunn, Patrick Bohman, Alexis Quinteros, et al.
Analytical Chemistry (2023) Vol. 95, Iss. 49, pp. 18130-18138
Closed Access | Times Cited: 12
Heavy chain variants affect light and heavy chains assembly of monoclonal antibody expressed by Pichia pastoris
Xiulong Gong, Kaixiong Ye, Ming-Qiang Xu, et al.
Preparative Biochemistry & Biotechnology (2025), pp. 1-8
Closed Access
A library approach for the de novo high-throughput isolation of humanized VHH domains with favorable developability properties following camelid immunization
Paul Arras, Han Byul Yoo, Lukas Pekar, et al.
mAbs (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 9
Roadmap for Drug Product Development and Manufacturing of Biologics
Krishnan Sampathkumar, Bruce A. Kerwin
Journal of Pharmaceutical Sciences (2023) Vol. 113, Iss. 2, pp. 314-331
Open Access | Times Cited: 9
Impact of Excipient Extraction and Buffer Exchange on Recombinant Monoclonal Antibody Stability
Deepika Sarin, Kunal Krishna, M. Reza Nejadnik, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 4, pp. 1872-1883
Open Access | Times Cited: 3
New technologies in therapeutic antibody development: The next frontier for treating infectious diseases
Sheila M. Keating, Brett W. Higgins
Antiviral Research (2024) Vol. 227, pp. 105902-105902
Closed Access | Times Cited: 3
Determining the affinities of high-affinity antibodies using KinExA and surface plasmon resonance
M. Frank Erasmus, Molly Dovner, Fortunato Ferrara, et al.
mAbs (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 7
Navigating large-volume subcutaneous injections of biopharmaceuticals: a systematic review of clinical pipelines and approved products
Philip Green, Andreas Schneider, Jakob Lange
mAbs (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Predicting deamidation and isomerization sites in therapeutic antibodies using structure-based in silico approaches
David Hoffmann, Joschka Bauer, Markus Kossner, et al.
mAbs (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Stability of Protein Pharmaceuticals: Recent Advances
Mark C. Manning, Ryan E. Holcomb, R. W. Payne, et al.
Pharmaceutical Research (2024) Vol. 41, Iss. 7, pp. 1301-1367
Closed Access | Times Cited: 2
ACE2-Fc and DPP4-Fc decoy receptors against SARS-CoV-2 and MERS-CoV variants: a quick therapeutic option for current and future coronaviruses outbreaks
Mohamed A. Alfaleh, Reem M. Alsulaiman, Sarah A. Almahboub, et al.
Antibody Therapeutics (2023) Vol. 7, Iss. 1, pp. 53-66
Open Access | Times Cited: 4
Predicting the clinical subcutaneous absorption rate constant of monoclonal antibodies using only the primary sequence: a machine learning approach
Ronghua Bei, Justin Thomas, Shiven Kapur, et al.
mAbs (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Comprehensive approaches to preclinical evaluation of monoclonal antibodies and their next-generation derivatives
Santanu Singh, Kajal Kachhawaha, Sumit K. Singh
Biochemical Pharmacology (2024) Vol. 225, pp. 116303-116303
Closed Access | Times Cited: 1
Taylor–Aris Dispersion-Assisted Mass Spectrometry for the Analysis of Native Proteins
Ruben Szabo, Gyöngyi Gyémánt, Cynthia Nagy, et al.
Analytical Chemistry (2024) Vol. 96, Iss. 28, pp. 11309-11317
Closed Access | Times Cited: 1
On the humanization of VHHs: Prospective case studies, experimental and computational characterization of structural determinants for functionality
Monica L. Fernández‐Quintero, Enrico Guarnera, Djordje Müsil, et al.
Protein Science (2024) Vol. 33, Iss. 11
Open Access | Times Cited: 1
In-Situ Monitoring of Protein Degradation in Therapeutic Antibody Formulations Using Intrinsic Tryptophan Fluorescence Emission Spectroscopy
Lennart Brack, Olivia M. Merkel, Rudolf Schroeder
(2024)
Closed Access
Is Lyophilization Key for Transportation and Storage of Biopharmaceutical Drug Products in Space?
Tim Menzen
Journal of Pharmaceutical Sciences (2024) Vol. 113, Iss. 7, pp. 1695-1700
Closed Access
SPEED‐MODE cell line development (CLD): Reducing Chinese hamster ovary (CHO) CLD timelines via earlier suspension adaptation and maximizing time spent in the exponential growth phase
Kavya Ganapathy, Cynthia Lam, Joni Tsukuda, et al.
Biotechnology Progress (2024) Vol. 40, Iss. 5
Closed Access
Suborgan Level Quantitation of Proteins in Tissues Delivered by Polymeric Nanocarriers
Dheeraj K. Agrohia, Ritabrita Goswami, Teerapong Jantarat, et al.
ACS Nano (2024) Vol. 18, Iss. 26, pp. 16808-16818
Closed Access
The Preliminary Establishment of Monoclonal Antibodies Production of Platform for Diagnostics Using Hybridoma Cells in Industrial
Shuwang Wu, Jing Wang, Qian Xiang, et al.
(2024)
Closed Access
Liquid-phase separations coupled with ion mobility-mass spectrometry for next-generation biopharmaceutical analysis
Devin M. Makey, Brandon T. Ruotolo
Expert Review of Proteomics (2024) Vol. 21, Iss. 5-6, pp. 259-270
Closed Access
A rapid method to monitor structural perturbations of high-concentrated therapeutic antibody solutions using Intrinsic Tryptophan Fluorescence Emission spectroscopy
Lennart Brack, Olivia M. Merkel, Rudolf Schroeder
European Journal of Pharmaceutics and Biopharmaceutics (2024) Vol. 201, pp. 114377-114377
Closed Access
Page 1 - Next Page

Scroll to top